Below please find daily updates pertaining to the latest in financial, business, and tax news:

GAO Report Links IRS Problems to Budget Cuts

April 24, 2014

The IRS could do a better job if it had more resources at its disposal, says the GAO, which has recommendations for the IRS on how it can improve its performance....

Earn CPE Credits at 2014 IRS Tax Forums

April 24, 2014

Enrolled agents and CPAs can earn as much as 18 credits by attending one of five IRS Nationwide Tax Forums this summer. The three-day events feature seminars, workshops, and a two-day expo....

Bramwell?s Lunch Beat: Lawmakers Weigh In on IRS Bonuses Issue

April 24, 2014

The menu for April 24 features specials on Russia scrambling on FATCA, arrests in ID theft and fake tax return scheme, could the US implement a tax lottery like Slovakia, and more....

Auditing Special Purpose Frameworks: the General Ledger

April 24, 2014

One of the most significant analytical procedures is reading, or scanning, the general ledger account activity. It can have a major effect on audit strategy....

FRF for SMEs Series?Statement of Financial Position, Part 1

April 23, 2014

Event Date: May 15, 2014, 1 pm ET...

Six Steps to Recover from Service Failures

April 23, 2014

Event Date: May 14, 2014, 2 pm ET...

IRS Responds to TIGTA Report on Bonuses

April 23, 2014

The agency said it is developing a policy linking conduct to performance awards for executives and senior-level employees ? and a similar policy for all IRS employees will be considered....

10 Mobile Apps Worth a Look

April 23, 2014

Are you looking for ways to make your mobile devices more useful? Whether or not you use the apps listed here, you should know what's out there for you and your clients. ...

Bramwell?s Lunch Beat: IRS May Want to Fix Its Bonus Policy

April 23, 2014

The menu for April 23 features specials on the London Stock Exchange changing audit firms, IRS heading to US Supreme Court, co-signers causing surprise defaults on student loans, and more....

How to Get Tax Breaks on Your Home

April 23, 2014

Consider the tax implications of decisions your clients may be making about their homes in 2014. The rules are complicated and the decisions could have major repercussions....

2 Corporate Titans Resisting Definition: Will Tomorrow's Mega-Companies "Do Everything?"

April 24, 2014

Wal-Mart and Amazon.com used to have straightforward business models -- not anymore. Supervalu shares retreat after Wednesday's surge...

Inside Valeant Pharmaceuticals' Bid for Allergan

April 24, 2014

Here?s why this pharmaceutical megamerger seems like a good deal for both companies....

Why Shares of Penn National Gaming, Inc Plunged Today

April 24, 2014

Is this meaningful or just another movement?...

Get Ready for E-Cigarettes to Light a Fire

April 24, 2014

The FDA surprises the industry with level-headed proposed regulations that should benefit the e-cigarette segments of Lorillard, Reynolds American, and Altria -- though e-cig opponents are sure to be fired up....

Earnings Roundup: Aetna, Inc. Continues the Medicaid Winning Steak

April 24, 2014

Aetna (AET) joined United Healthcare (UNH) and Centene (CNC) in reporting robust first quarter sales and profit growth tied to rising Medicaid enrollment....

Sarepta's Still a Gamble, Even With FDA Reversal

April 24, 2014

Will Sarepta finally get approval for eteplirsen?...

What You Should Know About Gilead's Sovaldi And Johnson & Johnson's Olysio

April 24, 2014

Johnson & Johnson's (JNJ) Olysio and Gilead's (GILD) Sovaldi posted blockbuster run rates in the first quarter, but sales could soon be challenged by AbbVie (ABBV), Bristol-Myers (BMY), and Merck (MRK)....

Why Investors Should Love Biogen's Earnings Miss

April 24, 2014

Biogen's shares slumbered through trading after the company's earnings release, but Tecfidera's impressive growth makes the future impressively bright for this biotech giant....

Illumina, Inc.: How the Market's Smartest Company is Living Up to the Hype

April 24, 2014

Illumina won rave reviews for its innovative technology after making the $1,000 genome possible, but the company showed off its financial prowess in the first quarter....

3 Drugs Johnson & Johnson?s Investors Better Know About

April 24, 2014

Johnson & Johnson's (JNJ) sales are being driven by a handful of fast-growing drugs. Here are three investors should be watching because of competitive threats from AstraZeneca (AZN), Pfizer (PFE), and Medivation (MDVN)....

Emochila CPA Websites